This statistic depicts the global pharmaceutical revenue – including prescription and over-the-counter drugs – from 2012 to 2026, categorized by technology. In 2019, biotechnology accounted for 266 billion U.S. dollars in drug revenue while conventional drugs accumulated 469 billion U.S. dollars, and unclassified technology accounted for 175 billion U.S. dollars of revenue. Biotechnology allows for the utilization of living systems and organisms to create pharmaceutical products. The use of synthetic humanized insulin is widely used for the treatment of diabetes.
…. more: Statista.com (Quelle/Source)
